Dyne Therapeutics (DYN) Shares Outstanding (Entity) (2019 - 2026)
Powered by 
Analysis
Dyne Therapeutics (DYN) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Dyne Therapeutics | 4.04 Bn | 4.04 Bn | - | 165.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.67 Mn |
| Mar 31, 2026 | 165.20 Mn |
| Dec 31, 2025 | 128.44 Mn |
| Sep 30, 2025 | 142.61 Mn |
| Jun 30, 2025 | 114.34 Mn |
| Mar 31, 2025 | 113.63 Mn |
| Dec 31, 2024 | 102.32 Mn |
| Sep 30, 2024 | 101.75 Mn |
| Jun 30, 2024 | 100.12 Mn |
| Mar 31, 2024 | 87.09 Mn |
| Dec 31, 2023 | 61.47 Mn |
| Sep 30, 2023 | 61.32 Mn |
| Jun 30, 2023 | 61.01 Mn |
| Mar 31, 2023 | 58.31 Mn |
| Dec 31, 2022 | 55.64 Mn |
| Sep 30, 2022 | 51.91 Mn |
| Jun 30, 2022 | 51.73 Mn |
| Mar 31, 2022 | 51.65 Mn |
| Dec 31, 2021 | 51.57 Mn |
| Sep 30, 2021 | 51.48 Mn |